Skip to content
Evidence Base for Pharmacogenetic Tests Still Lacking, APA Workgroup Finds
5/3/24 12:00 AM
FDA Issues Draft Guidance for Conducting Clinical Trials With Psychedelic Substances
6/27/23 12:00 AM
Non-White Patients May Be More Likely to Be Excluded From Alzheimer’s Disease Trials
7/7/21 12:00 AM
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Follow us on X
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Subscribe Here!
News From Current Issue
Special Report: Communicating the Neurobiology of MDD
Why Narcolepsy Is Often Missed—and How to Spot It
Integrating Psychiatric Pharmacists Into Practice
Read This Week's Update
